MedTrace Logo

POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE

NCT02536378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 692

Last updated 2020-07-29

Study results available
· View outcomes & findings →

Summary

The ROADSTER 2 Study is intended to evaluate real world usage of the ENROUTE Transcarotid Stent when used with the ENROUTE Transcarotid Neuroprotection System by physicians of varying experience with the transcarotid technique.

Conditions

  • Carotid Artery Disease

Sponsors & Collaborators

  • Silk Road Medical

    lead INDUSTRY

Principal Investigators

  • Vikram Kashyap, MD · University Hospital Case Medical Center Harrington Heart & Vascular Institute

  • Peter Schneider, MD · Kaiser Permanente

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-23
Primary Completion
2019-04-29
Completion
2019-04-29

Countries

  • United States
  • Germany
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02536378 on ClinicalTrials.gov